DDR1 contributes to kidney inflammation and fibrosis by promoting the phosphorylation of BCR and STAT3

Corina M. Borza(Vanderbilt University Medical Center), Ambra Pozzi(Vanderbilt University)
JCI Insight
December 23, 2021
10.1172/jci.insight.150887
Cited by 60

Related Papers

Soluble Eph A receptors inhibit tumor angiogenesis and progression in vivo
|Oncogene|2002|317
The Anti-tumorigenic Properties of Peroxisomal Proliferator-activated Receptor α Are Arachidonic Acid Epoxygenase-mediated
|Journal of Biological Chemistry|2010|83
Mouse EP3 α, β, and γ Receptor Variants Reduce Tumor Cell Proliferation and Tumorigenesis in Vivo
|Journal of Biological Chemistry|2008|28